<http://webisa.webdatacommons.org/prov/439046827>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/215775905> .
<http://webisa.webdatacommons.org/215775905>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/215775905>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<essentialaction.org> .
<http://webisa.webdatacommons.org/215775905>	<http://www.w3.org/ns/prov#value>	"The longer that PhRMA has exclusivity to its biologics, it means less savings realized for patients suffering from cancer, AIDs, and other diseases." .
<http://webisa.webdatacommons.org/prov/231735910>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/215775905> .